• Most Popular
  • Most Shared

Perlegen Sciences files to withdraw $115 mln IPO

Tue May 1, 2007 6:39am EDT

WASHINGTON, May 1 (Reuters) - Biopharmaceutical company Perlegen Sciences Inc. filed with regulators on Tuesday to withdraw its plans to raise up to $115 million in an initial public offering of common stock.

Regulatory News  |  IPOs

Perlegen said in a filing with the U.S. Securities and Exchange Commission that its withdrawal of the IPO was "consistent with the public interest and the protection of investors."

The company had planned to have Lehman Brothers, Deutsche Bank Securities, Piper Jaffray and Allen & Co. LLC underwrite the IPO and to list its stock on the Nasdaq under the symbol "PERL." PERL.O

Regulatory News
IPOs


More from Reuters

Photo

Plot exposes fissure in U.S. intelligence community

WASHINGTON (Reuters) - Last week's failed plot to bomb a U.S. passenger jet has exposed lingering fissures within the U.S. intelligence community, which had information from interviews and clandestine intercepts but did not put the pieces together, officials said.

» More Top News
Traders work in the pits at the The New York Mercantile Exchange, November 7, 2007. REUTERS/Brendan McDermid

Calling the market

A spectacular credit bust, two devastating stock market crashes ... the smart call this decade was to play it safe.  Full Article 

Global Markets
People walk past a branch of Bank of America in New York's financial district April 28, 2009. REUTERS/Brendan McDermid
Rolfe Winkler:

Move your money

Boycotting "too big to fail" banks is a great idea -- so long as investors remember that banks aren't the only ones responsible for the crisis.  Full Article 

    Commentary